… Study Rationale: There is an urgent need to identify effective, safe and inexpensive drugs for … Our objective is to identify drugs that are associated with a decreased risk of Parkinson’s in two large … to implement a pharmacoepidemiological study using two complementary approaches: (i) agnostic approach: in a study …

… Mendel of Denver, Colorado, recalled travels as a couple: to Africa on safari and, most recently, to Mexico. But … there’s one journey their passports can’t document—living with Lee’s Parkinson’s disease and Lewy Body Dementia (LBD), … and lack of knowledge. Even within the Parkinson’s community, many have never heard of Lewy Body Dementia and …

… Photo courtesy of AARP The Magazine Just in time for … he has experienced in the 26 years since he was diagnosed with Parkinson's disease (PD), the strength and support of … of the disease and feeling empowered by the PD community. In his interview filled with personal anecdotes, …

… The Michael J. Fox Foundation (MJFF) has stepped up efforts to connect locally with the Parkinson’s community, and with support groups in particular. “It’s an …

… policy at MJFF, introduces critical Parkinson’s statistics to help kick off the virtual briefing. One million people in … classic motor symptoms of Parkinson’s, and these issues can complicate other symptoms and affect long-term outcomes. … Board for Certified Counselors. Together, we collaborated with members of the Congressional Caucus on Parkinson’s …

… available and have a better-known safety profile than a completely new drug. Certain drugs used for treating other … diseases (e.g., hypertension, diabetes) have been linked to lower risk of Parkinson’s in epidemiological studies and … disease. Hypothesis: It is possible that more therapies with repurposing potential for Parkinson’s disease already …